GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sinocare Inc (SZSE:300298) » Definitions » LT-Debt-to-Total-Asset

Sinocare (SZSE:300298) LT-Debt-to-Total-Asset : 0.15 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Sinocare LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sinocare's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.15.

Sinocare's long-term debt to total assets ratio increased from Mar. 2023 (0.11) to Mar. 2024 (0.15). It may suggest that Sinocare is progressively becoming more dependent on debt to grow their business.


Sinocare LT-Debt-to-Total-Asset Historical Data

The historical data trend for Sinocare's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocare LT-Debt-to-Total-Asset Chart

Sinocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.13 0.12 0.16 0.15

Sinocare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.16 0.15 0.15 0.15

Sinocare LT-Debt-to-Total-Asset Calculation

Sinocare's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=892.393/5926.972
=0.15

Sinocare's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=874.323/5819.717
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocare  (SZSE:300298) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Sinocare LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Sinocare's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocare (SZSE:300298) Business Description

Traded in Other Exchanges
N/A
Address
No.265 Guyuan Road, Hi-tech Zone, Hunan Province, Changsha, CHN, 410205
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Executives
Li Shao Bo Directors, executives
Che Hong Jing Director
Wang Shi Min Executives
Huang An Guo Directors, executives
Directors, executives
Pan Shu Guang Securities Affairs Representative
Zhou Qing Hua Supervisors
Ning Gui Chun Supervisors
Wang Rui Securities Affairs Representative
Chen Ji Dong Supervisors
Che Hong Li Directors, executives
Zhang Fan Director

Sinocare (SZSE:300298) Headlines

No Headlines